Gene · 538
Papers3,096
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 3,096
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Characterization of tumor microenvironment and sensitive chemotherapy drugs based on cuproptosis-related signatures in renal cell carcinoma. | Aging (Albany NY) | 2023 | 37728407 | PubTator, text mining | PubMed |
| Cuproptosis-related gene subtypes predict prognosis in patients with head and neck squamous cell carcinoma. | J Otolaryngol Head Neck Surg | 2023 | 37697421 | PubTator, text mining | PubMed |
| Arterial Tortuosity Syndrome: Unraveling a Rare Vascular Disorder. | Cureus | 2023 | 37692180 | PubTator, text mining | PubMed |
| The Impact of ETV6-NTRK3 Oncogenic Gene Fusions on Molecular and Signaling Pathway Alterations. | Cancers (Basel) | 2023 | 37686522 | PubTator, text mining | PubMed |
| Retraction: MNK1-Induced eIF-4E Phosphorylation in Myeloma Cells: A Pathway Mediating IL-6-Induced Expansion and Expression of Genes Involved in Metabolic and Proteotoxic Responses. | PLoS One | 2023 | 37682824 | PubTator, text mining | PubMed |
| Comprehensive analysis and experimental validation reveal elevated CLCN4 is a promising biomarker in endometrial cancer. | Aging (Albany NY) | 2023 | 37671947 | PubTator, text mining | PubMed |
| MNK, mTOR or eIF4E-selecting the best anti-tumor target for blocking translation initiation. | Eur J Med Chem | 2023 | 37669595 | PubTator, text mining | PubMed |
| 4D-DIA quantitative proteomics revealed the core mechanism of diabetic retinopathy after berberine treatment. | Eur J Pharmacol | 2023 | 37659689 | PubTator, text mining | PubMed |
| Cuproptosis-related prognostic signatures predict the prognosis and immunotherapy in HCC patients. | Medicine (Baltimore) | 2023 | 37653738 | PubTator, text mining | PubMed |
| The microenvironment dictates glycocalyx construction and immune surveillance. | Res Sq | 2023 | 37645943 | PubTator, text mining | PubMed |
| Exploring cuproptosis as a mechanism and potential intervention target in cardiovascular diseases. | Front Pharmacol | 2023 | 37637426 | PubTator, text mining | PubMed |
| Prediction model of clinical prognosis and immunotherapy efficacy of gastric cancer based on level of expression of cuproptosis-related genes. | Heliyon | 2023 | 37636385 | PubTator, text mining | PubMed |
| OLR1 Is a Pan-Cancer Prognostic and Immunotherapeutic Predictor Associated with EMT and Cuproptosis in HNSCC. | Int J Mol Sci | 2023 | 37629087 | PubTator, text mining | PubMed |
| Cuproptosis- and m6A-Related lncRNAs for Prognosis of Hepatocellular Carcinoma. | Biology (Basel) | 2023 | 37626987 | PubTator, text mining | PubMed |
| The Role of Obesity in Breast Cancer Pathogenesis. | Cells | 2023 | 37626871 | PubTator, text mining | PubMed |
| Construction and validation of a cuproptosis-related diagnostic gene signature for atrial fibrillation based on ensemble learning. | Hereditas | 2023 | 37620966 | PubTator, text mining | PubMed |
| Construction and validation of cuproptosis-related lncRNA prediction signature for bladder cancer and immune infiltration analysis. | Aging (Albany NY) | 2023 | 37616061 | PubTator, text mining | PubMed |
| Construction of a cuproptosis-associated lncRNA prognostic signature for bladder cancer and experimental validation of cuproptosis-related lncRNA UBE2Q1-AS1. | Front Med (Lausanne) | 2023 | 37614950 | PubTator, text mining | PubMed |
| Cuproptosis-related gene SLC31A1 expression correlates with the prognosis and tumor immune microenvironment in glioma. | Funct Integr Genomics | 2023 | 37610668 | PubTator, text mining | PubMed |
| The emerging role of copper in depression. | Front Neurosci | 2023 | 37609453 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/538/papers?page=17